Showing 7 of 27 recruiting trials for “obsolete-hiv-related-hodgkin-lymphoma”
RecruitingNCT06822855 ↗
Changing Paragidms In The Prognostic Assessment Of Hodgkin Lymphoma
👨⚕️ Luminari Stefano, MD, Azienda USL - IRCCS di Reggio Emilia📍 12 sites📅 Started Jun 2022View details ↗
Safety and Efficacy of EX103 in Subjects with Relapsed/Refractory CD20-Positive Non-Hodgkin Lymphoma
👨⚕️ Junyuan Qi, MD, PHD, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences📍 4 sites📅 Started Nov 2021View details ↗
Clinical Investigation of Proton Treatment in Hodgkin Lymphoma Patients - PRO-Hodgkin
CD30 CAR T Cells, Relapsed CD30 Expressing Lymphoma (RELY-30)
Auto Stem Cell Transplant for Lymphoma Patients
👨⚕️ Veronika Bachanova, MD, Masonic Cancer Center, University of Minnesota📍 1 site📅 Started Apr 2017View details ↗
Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL
RecruitingNCT01790152 ↗
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
← PreviousPage 2 of 2
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →